Alloy vs NovoCare Pharmacy
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
NovoCare Pharmacy
Best for branded Wegovy at the lowest manufacturer-direct self-pay priceStarting at $199/mo
Side-by-Side Comparison
| Feature | Alloy | NovoCare Pharmacy |
|---|---|---|
| Overall Score | 7.4/10 | ✓8.7/10 |
| Starting Price | ✓$80/mo | $199/mo |
| Editorial Rating | 3.7 ★ /5 | ✓4.4 ★ /5 |
| Features | ✓8 features | 5 features |
| States Available | 0 | ✓50 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
NovoCare Pharmacy
Pros
- ✓First-party manufacturer pharmacy — the most authoritative branded Wegovy channel possible
- ✓$199/month intro pricing for Wegovy 0.25 mg and 0.5 mg starter doses (through 6/30/2026) is the lowest brand-name self-pay price for the FDA-approved Wegovy product
- ✓$349/month standard self-pay for full-dose Wegovy is well below the ~$1,300/month list price at retail pharmacies
- ✓Ships to all 50 states; no telehealth-platform middleman fees
- ✓Cold-chain logistics handled by Novo Nordisk directly — no risk of mishandling between manufacturer and patient
- ✓Insurance-billing path also available via the standard NovoCare savings program
Cons
- ✗Wegovy only — no semaglutide for type 2 diabetes (Ozempic), no compounded GLP-1, no tirzepatide
- ✗Requires an existing valid Wegovy prescription — NovoCare Pharmacy does not employ prescribing clinicians or operate a telehealth intake. You need a separate visit (PCP, endocrinologist, or another telehealth provider) to get the script first
- ✗$199 intro pricing is dose-restricted (0.25 mg / 0.5 mg only) and time-limited (through 6/30/2026) — most patients on the maintenance 1.7 / 2.4 mg dose pay $349/month
- ✗No clinical support included with the pharmacy fulfillment — your prescribing clinician handles titration and side-effect monitoring
- ✗Manufacturer-set pricing can change at any time
Our Verdict
NovoCare Pharmacy edges out Alloy with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. Alloy remains a solid alternative, especially if you're looking for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.